**Core Concept:** Essential thrombocythaemia (ET) is a clonal disorder of myeloproliferative neoplasm characterized by excessive production of platelets. JAK2 mutation is a common genetic abnormality found in ET patients.

**Why the Correct Answer is Right:** Essential thrombocythaemia is a clonal disorder characterized by increased production of platelets due to a mutation in the JAK2 gene. This gene belongs to the Janus kinase (JAK) family and is crucial for normal platelet production and function. The JAK2 mutation leads to uncontrolled platelet production and is responsible for the clinical manifestations of ET.

**Why Each Wrong Option is Incorrect:**

A. JAK2 mutation: This option refers to the correct answer, which is a JAK2 gene mutation responsible for ET.
B. MPL gene mutation: MPL gene mutations are known to cause another clonal disorder called myeloproliferative neoplasm (MPN), but they are not specific to ET.
C. CALR gene mutation: CALR gene mutations are also seen in MPNs like ET but are more common in primary myelofibrosis (PMF) rather than ET.
D. CALR-ET mutation: This option is incorrect because CALR mutations are not specific to ET, as mentioned above.

**Clinical Pearl / High-Yield Fact:** JAK2 mutations are highly specific and sensitive markers for diagnosing ET and other MPNs. Identifying JAK2 mutation helps differentiate ET from other similar disorders like polycythemia vera (PV) and primary myelofibrosis (PMF).

**Correct Answer:** .